Published in Medical Letter on the CDC and FDA, March 2nd, 2003
The agency believes that, based on present information, this incident poses no public health risk. Nevertheless, if confirmed, it would represent a significant breach of the FDA requirements for this study - warranting strong action against the responsible parties.
To date, this appears to be an isolated incident in which measures already in place to dispose of experimental transgenic animals may not have been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.